Search Results
Results found for "Denise Wootten"
Posts (54)
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
Sexton , Denise Wootten , et al., for their work on Isoquinoline small molecule ligands are agonists
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Denise Wootten and colleagues has highlighted the importance of extracellular loop 2 (ECL2) in stabilizing Wootten, D., et al., The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased
- From GPCR Data Chaos to Decisive Action
Decisions stall. And momentum quietly dies. GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide. you move faster—with fewer blind spots, tighter execution, and a clear line of sight to your next key decision teams don’t need more data— they need clarity ✅ Yamina’s Corner helps teams move from data chaos to decisive
Other Pages (32)
- Ep 149 with Dr Arthur Christopoulos
. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance
- Ep 148 with Dr Arthur Christopoulos
. - Yamina will attempt to book Denise for a future podcast episode. Towards the end, they focused on Arthur's transition to become Dean and his decision to move from Australia Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake The conversation also touched upon Arthur's career decisions, his scientific achievements, and the importance
- Biotech Growth | Dr. GPCR Ecosystem
Take your idea, platform, or early data and turn it into a strategic roadmap with clear decisions, timelines How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data Prioritize assays based on project phase and decision points Map go/no-go logic that guides program momentum confidence Trusted by Biotech Innovators Before working with Yamina, we were navigating challenging decisions You walk away with a decision-ready roadmap, improved CRO output, and faster movement through your discovery





